GeneFirst
Abingdon
About GeneFirst
GeneFirst is a molecular diagnostics company working predominantly in the fields of infectious disease, cancer diagnostics and personalized medicine. GeneFirst offers robust easy-to-use, sensitive, and affordable molecular diagnostics technologies and products to researchers, clinicians, and drug companies to enable accurate diagnosis and the delivery of safe and effective medicines. Its patented technologies allow for simultaneous detection of multiple targets in one reaction.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.4M
- Last round: Grant (Nov 2017)
- Website: genefirst.com
- Phone: +44 (0) 1865 407400
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Medical Device, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/genefirst-162960 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.